Factors affecting the management of outcome in elderly patients with acute myocardial infarction particularly with regard to reperfusion: Data from the French regional RICO survey

Gerontology

Volumn 51, Issue 6, 2005, Pages 409-415

  Popitean, Laura ^a   Barthez, Olivier ^a   Rioufol, Gilles ^a   Zeller, Marianne ^a   Arveux, Isabelle ^a   Dentan, Gilles ^b   Laurent, Yves ^c   Janin Manificat, Luc ^c   Fraison, Michel ^a   Beer, Jean Claude ^a   Makki, Hamid ^c   Pfitzenmeyer, Pierre ^a   Cottin, Yves ^a,d  

^a HÔPITAL DU BOCAGE   (France)

^b Clinique de Fontaine   (France)

^c CENTRE HOSPITALIER   (France)

^d DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Aging; Myocardial infarction; Prognosis; Reperfusion

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NITRATE;

ACUTE HEART INFARCTION; AGED; AGING; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HEART EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HOSPITALIZATION; HUMAN; INCIDENCE; LYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; RISK FACTORS; TREATMENT OUTCOME;

EID: 27944456800     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088706     Document Type: Article

References (29)

1. Gillum BS, Graves EJ, Wood E: National hospital discharge survey: vital and health statistics, series 13. Data from the National Health Survey: 133:I-v. 1998:1-51.
2. Goldberg RJ, McCormick D, Gurwitz JH, Yarzebski J, Lessard D, Gore JM: Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol 1998;82:1311-1317.
3. Gurwitz JH, Col NF, Avorn J: The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992;268:1417-1422.
4. White HD, Barbash GI, Califf RM, Simes RJ, Granger CB, Weaver WD, Kleiman NS, Aylward PE, Gore JM, Vahanian A, Lee KL, Ross AM, Topol EJ: Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I Trial. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries Trial. Circulation 1996;94:1826-1833.
5. Paul SD, O'Gara PT, Mahjoub ZA, et al: Geriatric patients with acute myocardial infarction: cardiac risk factor profiles, presentation, thrombolysis, coronary interventions, and prognosis. Am Heart J 1996;131:710-715.
6. Barakat K, Wilkinson P, Deaner A, Fluck D, Ranjadayalan K, Timmis A: How should age affect management of acute myocardial infarction? A prospective cohort study. Lancet 1999;353:955-959.
7. Mehta RH, Rathore SS, Radford MJ, Wang Y, Wang Y, Krumholz HM: Acute myocardial infarction in the elderly: differences by age. J Am Coll Cardiol 2001;38:736-741.
8. Danchin N, Angioi M, Demicheli T, Vaur L, Genes N, Ferrieres J, Etienne S, Cambou JP; USIK Registry Participants: effect of reperfusion therapy on long-term outcome in patients >70 years of age. Am J Cardiol 2002;90:1142-1145.
9. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators: A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997;337:1118-1123.
10. Vokonas PS, Kannel WB, Cupples LA: Incidence and prognosis of unrecognized myocardial infarction in the elderly: the Framingham Study. J Am Coll Cardiol 1988:51A.
11. Horvilleur J, Benamer H, Aubry P, Himbert D, Gaultier C, Feldman L, Steg PG, Juliard JM: Myocardial revascularization at the acute phase of myocardial infarction in the octogenarian. Arch Mal Cœur Vaiss 2002;95:143-149.
12. Mehta RH, Rathore SS, Radford MJ, Wang Y, Wang Y, Krumholz HM: Acute myocardial infarction in the elderly: differences by age. J Am Coll Cardiol 2001;38:736-741.
13. Ruiz-Bailén M, Aguayo de Hoyos E, Ramos-Cuadra JA, Diaz-Castellanos MA, Issa-Khozouz Z, Reina-Toral A, Lopez-Martinez A, Calatrava-Lopez J, Laynez-Bretones F, Castillo-Parra JC, de la Torre-Prados MV for the ARIAM Group: Influence of age on clinical course, management and mortality of acute myocardial infarction in the Spanish population. Int J Cardiol 2002;85:285-296.
14. Rich MW, Bosner MS, Chung MK, Shen J, McKenzie JP: Is age an independent predictor of early and late mortality in patients with acute myocardial infarction? Am J Med 1992;92:7-13.
15. Smith SC, Gilpin E, Ahnve S, et al: Outlook for acute myocardial infarction in the very elderly compared with that in patients 65-75 years. J Am Coll Cardiol 1990;16:784-792.
16. Gregoratos G: Clinical manifestations of acute myocardial infarction in older patients. Am J Geriatr Cardiol 2001;10:345-347.
17. Myocardial infarction redefined: A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
18. Spirito P, Maron BJ: Influence of aging on Doppler echocardiographic indices of left ventricular diastolic function. Br Heart J 1988;59:672-679.
19. Avolio AP, Deng FQ, Li WQ, Luo YF, Huang ZD, Xing LF, O'Rourke MF: Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 1985;71:202-210.
20. Gerstenblith G, Frederiksen J, Yin FC, Fortuin NJ, Lakatta EG, Weisfeldt ML: Echocardiographic assessment of a normal adult aging population. Circulation 1977;56:273-278.
21. The Gusto Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.
22. Berger AK, Radford MJ, Krumbolz HM: Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: analysis of the cooperative cardiovascular project. Am Heart J 2000;139:985-992.
23. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group: Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;ii:349-360.
24. AIMS Trial Study Group: Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988;i:545-549.
25. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i:397-402.
26. The ISAM Study Group: A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM). Mortality, morbidity, and infarct size at 21 days. N Engl J Med 1986;314:1465-1471.
27. Wilcox RG, von der Lippe G, Olsson CG, et al: Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of early Thrombolysis (ASSET). Lancet 1988;ii:525-530.
28. Berger AK, Radford MJ, Wang Y: Thrombolytic therapy in older patients. J Am Coll Cardiol 2000;36:366-374.
29. Thiemann DR, Coresh J, Schulmann SP: Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation 2000;101:2239-2246.